Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Elnusa Tbk. (ELSA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance

Elnusa Tbk.Trade
Organon Pharma Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Elnusa Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Elnusa Tbk. trades at Rp725 (market cap 5.33T, 33.14M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Elnusa Tbk. is far larger — about 51.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.

ELSASCPI
Market Cap
5.33T104.4B
Volume
33.14M
Lot
331.38K
Turnover
24.44B
Average Price
737.47
Value
24.44B
Indicative Equilibrium Price
725
Indicative Equilibrium Volume
24.27K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ELSA
View details
SCPI
View details

About Elnusa Tbk.

PT Elnusa Tbk (Company) was established under the name of PT Elektronika Nusantara on January 25, 1969 based on notarial deed No.18 of Tan Thong Kie, S.H., dated January 25, 1969, as amended by notarial deed No. 10 of the same notary dated February 13, 1969. The Company’s articles of association has been amended several times, most recently by notarial deed No. 2 of Soegeng Santosa, S.H., dated Jan 7, 2002, concerning among others, the change in the Company’s name and public offering.

Read more on ELSA

About Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Read more on SCPI